@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/immunosuppressive-permament-medications> a fhir:ValueSet;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "immunosuppressive-permament-medications"];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "generated" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=116566001\">116566001</a></td><td>Steroid (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=416798007\">416798007</a></td><td>Substance with calcineurin inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=372669002\">372669002</a></td><td>Alkylating agent (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=430866006\">430866006</a></td><td>Substance with interleukin 1 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=784015001\">784015001</a></td><td>Substance with interleukin 6 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=771592004\">771592004</a></td><td>Substance with interleukin 23 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=870401008\">870401008</a></td><td>Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=768651008\">768651008</a></td><td>Antithymocyte immunoglobulin (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=372917005\">372917005</a></td><td>Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=48583005\">48583005</a></td><td>Immunoglobulin E (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=49327004\">49327004</a></td><td>Interferon (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=74964007\">74964007</a></td><td>Other (qualifier value)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=260413007\">260413007</a></td><td>None (qualifier value)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=261665006\">261665006</a></td><td>Unknown (qualifier value)</td></tr></table></li><li>Include these codes as defined in <code>http://fhir.de/CodeSystem/bfarm/atc</code> version <code>2020</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L01EG\">L01EG</a></td><td>Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren</td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L01B\">L01B</a></td><td>ANTIMETABOLITEN</td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L04AB\">L04AB</a></td><td>Tumornekrosefaktor alpha (TNF-alpha)-Inhibitoren</td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L01EJ\">L01EJ</a></td><td>Janus-assoziierte Kinase (JAK)-Inhibitoren</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-napkon-immunosuppresive-medications.html\"><code>https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-immunosuppresive-medications</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000001\">000001</a></td><td>Sphingosine analogue (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000002\">000002</a></td><td>Substance with interleukin 2 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000003\">000003</a></td><td>Substance with interleukin 17 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000004\">000004</a></td><td>Anti-CD20 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000005\">000005</a></td><td>Anti-CD52 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000006\">000006</a></td><td>Anti-CD3 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000007\">000007</a></td><td>Anti-CD3/CD19 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000008\">000008</a></td><td>Substance with Integrin inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-immunosuppresive-medications.html#napkon-immunosuppresive-medications-000009\">000009</a></td><td>Substance with B cell activating factor inhibitor mechanism of action (substance)</td></tr></table></li></ul></div>"
  ];
  fhir:ValueSet.url [ fhir:value "https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/immunosuppressive-permament-medications"];
  fhir:ValueSet.version [ fhir:value "0.1.0"];
  fhir:ValueSet.name [ fhir:value "ImmunosuppressivePermanentMedications"];
  fhir:ValueSet.title [ fhir:value "Immunosuppressive Permanent Medications"];
  fhir:ValueSet.status [ fhir:value "draft"];
  fhir:ValueSet.date [ fhir:value "2021-10-05"^^xsd:date];
  fhir:ValueSet.publisher [ fhir:value "BIH @ Charité"];
  fhir:ValueSet.contact [
     fhir:index 0;
     fhir:ContactDetail.name [ fhir:value "BIH @ Charité" ];
     fhir:ContactDetail.telecom [
       fhir:index 0;
       fhir:ContactPoint.system [ fhir:value "url" ];
       fhir:ContactPoint.value [ fhir:value "https://www.netzwerk-universitaetsmedizin.de" ]
     ]
  ];
  fhir:ValueSet.compose [
     fhir:ValueSet.compose.include [
       fhir:index 0;
       fhir:ValueSet.compose.include.system [ fhir:value "http://snomed.info/sct" ];
       fhir:ValueSet.compose.include.concept [
         fhir:index 0;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "116566001" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Steroid (substance)" ]
       ], [
         fhir:index 1;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "416798007" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with calcineurin inhibitor mechanism of action (substance)" ]
       ], [
         fhir:index 2;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "372669002" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Alkylating agent (substance)" ]
       ], [
         fhir:index 3;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "430866006" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with interleukin 1 receptor antagonist mechanism of action (substance)" ]
       ], [
         fhir:index 4;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "784015001" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with interleukin 6 receptor antagonist mechanism of action (substance)" ]
       ], [
         fhir:index 5;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "771592004" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with interleukin 23 receptor antagonist mechanism of action (substance)" ]
       ], [
         fhir:index 6;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "870401008" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance)" ]
       ], [
         fhir:index 7;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "768651008" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Antithymocyte immunoglobulin (substance)" ]
       ], [
         fhir:index 8;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "372917005" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)" ]
       ], [
         fhir:index 9;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "48583005" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Immunoglobulin E (substance)" ]
       ], [
         fhir:index 10;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "49327004" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Interferon (substance)" ]
       ], [
         fhir:index 11;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "74964007" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Other (qualifier value)" ]
       ], [
         fhir:index 12;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "260413007" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "None (qualifier value)" ]
       ], [
         fhir:index 13;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "261665006" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Unknown (qualifier value)" ]
       ]
     ], [
       fhir:index 1;
       fhir:ValueSet.compose.include.system [ fhir:value "http://fhir.de/CodeSystem/bfarm/atc" ];
       fhir:ValueSet.compose.include.version [ fhir:value "2020" ];
       fhir:ValueSet.compose.include.concept [
         fhir:index 0;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01EG" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren" ]
       ], [
         fhir:index 1;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01B" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "ANTIMETABOLITEN" ]
       ], [
         fhir:index 2;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L04AB" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Tumornekrosefaktor alpha (TNF-alpha)-Inhibitoren" ]
       ], [
         fhir:index 3;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01EJ" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Janus-assoziierte Kinase (JAK)-Inhibitoren" ]
       ]
     ], [
       fhir:index 2;
       fhir:ValueSet.compose.include.system [ fhir:value "https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-immunosuppresive-medications" ];
       fhir:ValueSet.compose.include.concept [
         fhir:index 0;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000001" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Sphingosine analogue (substance)" ]
       ], [
         fhir:index 1;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000002" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with interleukin 2 receptor antagonist mechanism of action (substance)" ]
       ], [
         fhir:index 2;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000003" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with interleukin 17 receptor antagonist mechanism of action (substance)" ]
       ], [
         fhir:index 3;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000004" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Anti-CD20 antibody (substance)" ]
       ], [
         fhir:index 4;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000005" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Anti-CD52 antibody (substance)" ]
       ], [
         fhir:index 5;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000006" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Anti-CD3 antibody (substance)" ]
       ], [
         fhir:index 6;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000007" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Anti-CD3/CD19 antibody (substance)" ]
       ], [
         fhir:index 7;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000008" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with Integrin inhibitor mechanism of action (substance)" ]
       ], [
         fhir:index 8;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "000009" ];
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Substance with B cell activating factor inhibitor mechanism of action (substance)" ]
       ]
     ]
  ] .

# - ontology header ------------------------------------------------------------

<https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/immunosuppressive-permament-medications.ttl> a owl:Ontology;
  owl:imports fhir:fhir.ttl .

# -------------------------------------------------------------------------------------

